INSIGHTS ON PHARMACEUTICAL LOGISTICS

• Friendshoring: A Strategic Shift In Pharma Supply Chains

  To safeguard the consistent delivery of essential therapies to patients around the world, biopharmaceutical companies, alongside their CDMO partners, are rethinking traditional supply models.

• Pharmaceutical Supply Chain Management Best Practices

  Explore strategies for effective supply chain management and overcoming modern supply chain challenges in the pharmaceutical industry.

• Clinical, Commercial Packaging: Delivering Next-Gen Therapies

  See how strategic, agile, and sustainable packaging is transforming drug delivery into a key driver of speed, safety, and patient-centric innovation.

• How To Select The Right Fill-Finish CDMO For Phase I–II

  Early‑phase programs require flexible, technically aligned fill‑finish partners. Mid‑sized CDMOs offer a balance of agility, infrastructure, and regulatory maturity suited to Phase I–II needs.

• Windsor Framework: What Is It?

  9/2/2025

  Learn about the Windsor Framework and how it addresses the challenges of medicine supply chains between the UK and the EU, creating stability and certainty in the post-Brexit world.

• The Crucial Role Of Cleaning In Effective VPHP Decontamination For Isolators

  12/27/2024

  Effective isolator cleaning is crucial for vapor phase hydrogen peroxide (VPHP) decontamination. Proper tools, techniques, and training ensure sterility, and regulatory compliance.

• Stick-Pack Benefits For Pharmaceuticals And Nutraceuticals

  10/24/2024

  Explore the key advantages of stick-pack formats for pharmaceuticals and nutraceuticals, from enhanced product safety and cost-efficiency to improved compliance and marketability.

• 5 Signs You've Outgrown Your Quality Management System (QMS)

  12/27/2024

  An outdated QMS limits growth. Explore how upgrading to an advanced, configurable system like MasterControl can ensure scalability, automation and innovation. 

• Shedding Light On Photo-Stability Forced Degradation

  11/26/2024

  Ensure the stability and safety of your drug products by utilizing comprehensive forced degradation and photo-stability testing, guided by ICH and FDA standards, to identify degradation pathways and assess light exposure risks.